157 related articles for article (PubMed ID: 23328622)
21. Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.
Lapa C; Knott M; Rasche L; Herrmann K; Buck AK; Rosenwald A
Eur J Haematol; 2014 Dec; 93(6):545-6. PubMed ID: 24612353
[No Abstract] [Full Text] [Related]
22. Subcutaneous panniculitis-like T-cell lymphoma with extracutaneous dissemination demonstrated on FDG PET/CT.
Babb A; Zerizer I; Naresh KN; Macdonald D
Am J Hematol; 2011 Apr; 86(4):375-6. PubMed ID: 21442643
[No Abstract] [Full Text] [Related]
23. F-18 FDG uptake due to acinetobacter infection causing misinterpretation of treatment response in a lymphoma patient.
Yildiz R; Coskun U; Kapucu O; Kaya AO; Akdemir UO; Benekli M; Buyukberber S
Clin Nucl Med; 2007 Jun; 32(6):471-3. PubMed ID: 17515759
[No Abstract] [Full Text] [Related]
24. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.
Delbeke D; Stroobants S; de Kerviler E; Gisselbrecht C; Meignan M; Conti PS
Oncologist; 2009; 14 Suppl 2():30-40. PubMed ID: 19819922
[TBL] [Abstract][Full Text] [Related]
25. Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: a report of two cases.
Molin D; Hagberg H; Suurküla M; Aström G
Acta Oncol; 2010 May; 49(4):526-8. PubMed ID: 20397779
[No Abstract] [Full Text] [Related]
26. Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography.
Hoekstra OS; van Lingen A; Ossenkoppele GJ; Golding R; Teule GJ
Eur J Nucl Med; 1993 Dec; 20(12):1214-7. PubMed ID: 8299657
[TBL] [Abstract][Full Text] [Related]
27. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
28. Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma.
Herrmann K; Wieder HA; Buck AK; Schöffel M; Krause BJ; Fend F; Schuster T; Meyer zum Büschenfelde C; Wester HJ; Duyster J; Peschel C; Schwaiger M; Dechow T
Clin Cancer Res; 2007 Jun; 13(12):3552-8. PubMed ID: 17575218
[TBL] [Abstract][Full Text] [Related]
29. Nephrotic syndrome leading to the diagnosis of classical Hodgkin's lymphoma in a 13-year-old girl.
Escobar H; Yoshimi A; Hoffmann R; van Buiren M; Wild D; Folkens JU; Pohl M; Kontny U
Klin Padiatr; 2012 Apr; 224(3):191-2. PubMed ID: 22513794
[No Abstract] [Full Text] [Related]
30. Greater curability in advanced Hodgkin's disease?
Portlock CS
Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
[No Abstract] [Full Text] [Related]
31. Positron emission tomography / computerized tomography evaluation of primary Hodgkin's disease of liver.
Gota VS; Purandare NC; Gujral S; Shah S; Nair R; Rangarajan V
Indian J Cancer; 2009; 46(3):237-9. PubMed ID: 19574678
[TBL] [Abstract][Full Text] [Related]
32. Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition.
Metwally H; Courbon F; David I; Filleron T; Blouet A; Rives M; Izar F; Zerdoud S; Plat G; Vial J; Robert A; Laprie A
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):793-9. PubMed ID: 20615626
[TBL] [Abstract][Full Text] [Related]
33. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
Sagar TG; Chandra A; Raman SG
Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
[No Abstract] [Full Text] [Related]
34. High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
Kedmi M; Apel A; Davidson T; Levi I; Dann EJ; Polliack A; Ben-Bassat I; Nagler A; Avigdor A
Acta Haematol; 2016; 135(3):156-61. PubMed ID: 26588173
[TBL] [Abstract][Full Text] [Related]
35. Functional imaging of Hodgkin's disease with FDG-PET and gallium-67.
Willkomm P; Palmedo H; Grünwald F; Ruhlmann J; Biersack HJ
Nuklearmedizin; 1998; 37(7):251-3. PubMed ID: 9830616
[TBL] [Abstract][Full Text] [Related]
36. [Primary malignant non-Hodgkin's lymphoma of the heart].
Iwuagwu OC; Kober R
Rofo; 2002 Dec; 174(12):1578-9. PubMed ID: 12471533
[No Abstract] [Full Text] [Related]
37. A 10-year experience with treatment of high and standard risk Hodgkin disease: six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved.
Dann EJ; Blumenfeld Z; Bar-Shalom R; Avivi I; Ben-Shachar M; Goor O; Libster D; Gaitini D; Rowe JM; Epelbaum R
Am J Hematol; 2012 Jan; 87(1):32-6. PubMed ID: 21956220
[TBL] [Abstract][Full Text] [Related]
38. Fluorodeoxyglucose positron emission tomography in primary thyroid lymphoma with coexisting lymphocytic thyroiditis.
Arabi M; Dvorak R; Smith LB; Kujawski L; Gross MD
Thyroid; 2011 Oct; 21(10):1153-6. PubMed ID: 21875367
[TBL] [Abstract][Full Text] [Related]
39. [Bilateral primary non-Hodgkin's lymphomas of the adrenals].
Rezgui-Marhoul L; Bouslama K; Bouchriha M; Harmel A; Mzabi-Rgaya S; Hendaoui L; Ben Dridi M
Ann Med Interne (Paris); 2003 Dec; 154(8):549-51. PubMed ID: 15037833
[TBL] [Abstract][Full Text] [Related]
40. [Computed tomographic and sonographic control of the treatment of non-Hodgkin's lymphoma of the stomach].
Köster O; Harder T
Rofo; 1982 Dec; 137(6):727-9. PubMed ID: 6218055
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
